PY
Payden Equity Income Fund Adviser Cl
PYVAX · NASDAQ
$18.83 +0.00% (+$0.00)
1M -1.58%
Market Cap $1.35B
P/E Ratio 12.06x
Div. Yield 5.34%
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
49 /100
Fair P/E 12.06x
P/S 146.38x
P/B 2.11x
Growth
49 /100
Stable EPS growth 17.67%
Rev. growth 7.38%
Book val. growth 1.19%
Profitability
83 /100
Strong Net margin 1,213.69%
Op. margin 23.83%
Gross margin N/A
Quality
75 /100
Excellent ROA 17.26%
Asset turnover 0.01x
ROIC N/A
Debt
42 /100
Moderate Current ratio 0.73x
Debt/Equity N/A
Int. coverage N/A
Stability
57 /100
Moderate Beta 0.78x
Rev. volatility 6.24%
EPS volatility 197.16%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PYVAX
Online
Sector
Financial Services
Industry
Asset Management - Income
CEO
-
Employees
-
Headquarters
Los Angeles